| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |